Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 28 October 2009, doi:10.1136/bmj.b4395
Cite this as: BMJ 2009;339:b4395
| The first 150 words of the full text of this article appear below. |
We read Bischoff-Ferrari and colleagues meta-analysis with astonishment, because it does not consider potential side effects of vitamin D and its toxicity.1 This is further evidence that treatment harms are regularly under-reported, even when the information is accessible in primary studies.2
As long as data on harm are missing, Bischoff-Ferrari and colleagues meta-analysis does not permit an unbiased and objective assessment of the balance between risks and benefit of vitamin D.1 This is especially important in preventive options because patients are confronted with decisions on long term treatment that might (or might not) prevent events in the remote future.
Vitamin D and its analogues are not harmless—gastrointestinal symptoms and renal disease have been reported.3 We therefore request Bischoff-Ferrari and colleagues to prepare an amendment on the side effects and toxicity of vitamin D. Because randomised controlled trials often do not reflect the underlying risk-benefit profiles of treatment options,4 inclusion of
Gabriele Meyer, professor of clinical nursing research1, Sascha Köpke, research fellow and senior researcher2
1 University of Witten/Herdecke, 58453 Witten, Germany, 2 University of Hamburg, Unit of Health Sciences and Education, Hamburg, Germany
Gabriele.Meyer@uni-wh.de
Read all Rapid Responses